To check for the co-occurrence of the KRAS oncogene with non-synonymous mutations within an SH gene, we used the cohort of all KRAS mutated cancers founded in the TCGA dataset (i.e., 466 KRAS mutated out of 6953 cancers) including a smaller cohort of 72 KRAS mutated LUAD samples (i.e., out of 230 LUAD cancers). Here, KRAS is linked to cancer.